Cancer Clinical Trials
This is a current listing of active clinical trials at the Aspirus Regional Cancer Center. From this list you can select a specific cancer that you are interested in (for example, breast or colon cancer) and then review the clinical trials that are active at the Aspirus Regional Cancer Center for that specific disease.
Lung Cancer - Advanced or Replapsed Non-Small Cell
Trial Name: A Phase I, Intrapatient Dose-Escalation Study of Sorafenib In Advanced or Relapsed Non-Small Cell Lung Cancer (NSCLC).
Protocol ID: CO08511
Any malabsorption problem.
Enrollment: • About 44 participants
No direct benefit is guaranteed to you from participating in this study. Taking part in this study may or may not affect your cancer. It is also possible that sorafenib will prove to be less effective than other treatments for your cancer. In the future, people with cancer may have better treatment available because of knowledge gained from this study.
These clinical trial overviews are intended to provide a brief overview of the clinical trial. To help determine whether the trial is appropriate for you, the major eligibility criteria are listed above. To obtain more information on the eligibility and the treatment plan, please contact our Oncology Clinical Research Coordinator, Beth Knetter at 715-847-2353 or 1-800-283-2881, ext.72353.
Created: Jan 18, 2013
Updated: Jan 18, 2013